Listeria Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting
Condition:   2nd-line, 3rd-line and Greater Metastatic Pancreatic CancerInterventions:   Biological: GVAX Pancreas Vaccine;   Biological: CRS-207;   Drug: gemcitabine, capecitabine, 5-FU, irinotecan or erlotinib;   Drug: cyclophosphamideSponsor:   Aduro BioTech, Inc.Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2013 Category: Research Source Type: clinical trials

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting
Condition:   2nd-line, 3rd-line and Greater Metastatic Pancreatic CancerInterventions:   Biological: GVAX Pancreas Vaccine;   Biological: CRS-207;   Drug: gemcitabine, capecitabine, 5-FU, irinotecan or erlotinib;   Drug: cyclophosphamideSponsor:   Aduro BioTech, Inc.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2013 Category: Research Source Type: clinical trials

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Condition:   Malignant Pleural MesotheliomaIntervention:   Biological: Vaccine plus chemotherapySponsor:   Aduro BioTech, Inc.Recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2012 Category: Research Source Type: clinical trials

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Condition:   Malignant Pleural MesotheliomaInterventions:   Biological: Vaccine plus chemotherapy;   Biological: Vaccine with cyclophosphamide plus chemotherapySponsor:   Aduro BioTech, Inc.Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2012 Category: Research Source Type: clinical trials

Safety and Efficacy of Listeria and GVAX in Pancreatic Cancer
Condition:   Pancreatic CancerInterventions:   Drug: GVAX Pancreas, Cyclophosphamide and CRS-207;   Drug: GVAX Pancreas and CyclophosphamideSponsors:   Aduro BioTech, Inc.;   Johns Hopkins UniversityActive, not recruiting - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2011 Category: Research Source Type: clinical trials

Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer
Condition:   Pancreatic CancerInterventions:   Biological: GVAX Pancreas;   Biological: CRS-207;   Drug: CyclophosphamideSponsors:   Aduro BioTech, Inc.;   Johns Hopkins UniversityActive, not recruiting - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2011 Category: Research Source Type: clinical trials